Linezolid-induced rare triad of hypoglycaemia, bone marrow suppression and hyponatraemia in elderly.
WHAT IS KNOWN AND OBJECTIVE: Linezolid, a member of the oxazolidinone class of antibacterial drugs, is approved by the US Food and Drug Administration (FDA) for the treatment of vancomycin-resistant Enterococcus faecium infections, nosocomial and communit.....